Fifteen years later, Philip Morris, whose brands include Marlboro and Chesterfield, generates a quarter of its $28 billion in sales from smoke-free products, and aims to boost that share to more than half by 2025. But efforts to reinvent the cigarette haven’t weakened skepticism among anti-smoking groups that Philip Morris is truly aiming for a smoke-free future. For some, there’s quite simply something wrong with a tobacco company owning a firm that makes drugs to treat respiratory illnesses. The European Respiratory Society’s constitution and bylaws, for example, reject any links — even perceived links — to the tobacco industry. For Philip Morris Chief Executive Officer Jacek Olczak, ownership concerns aren’t justified.

Source: Mint July 21, 2021 09:22 UTC